Heart Patients Face 2-4 Times Higher Suicide Risk – Yet Cardiology Remains Silent

Patients hospitalised with serious heart conditions face significantly elevated suicide risk, yet suicide prevention remains almost entirely absent from cardiology care pathways across the NHS and internationally. A new editorial in The BMJ highlights a critical blind spot in how the medical profession approaches mental health alongside cardiovascular disease treatment.

The analysis reveals that people with acute coronary syndrome, heart failure, and those who have received cardiac implantable electronic devices (such as pacemakers) are between two and four times more likely to die by suicide compared with the general population. Despite this stark disparity, neither major international cardiology guidelines—published in 2025 by the European Society of Cardiology and the American Heart Association—prioritise suicide prevention adequately, the editorial argues.

“Although cardiovascular health is carefully monitored and optimised, suicide remains underrecognised in cardiology,” the BMJ editorial states. “Cardiology must systematically fulfil its responsibility in suicide prevention.”

The disconnect is striking. Cardiologists routinely monitor patients’ blood pressure, cholesterol levels, and other physiological markers with precision. Yet the mental health crisis unfolding in this vulnerable population often goes undetected.

Recent research using UK Biobank data provides concerning evidence. Patients hospitalised with cardiovascular disease were 83 per cent more likely to be diagnosed with psychiatric conditions including anxiety, depression, and other mental health disorders compared with people without heart disease. Critically, this heightened psychiatric risk persisted even after accounting for genetic factors, suggesting the stress and trauma of cardiovascular illness itself plays a significant role.

The period immediately following a cardiovascular event represents a particularly acute window of vulnerability. UK research demonstrated that patients hospitalised with heart disease faced the highest risk of developing psychiatric conditions within the first year of their cardiovascular diagnosis. This acute phase—when patients are adjusting to diagnosis, facing lifestyle changes, and grappling with mortality concerns—appears to be when psychological support is most urgently needed.

The National Institute for Health and Care Excellence (NICE) has previously identified physical illness as a high-risk factor for suicide in its clinical guidance. The NHS five-year suicide prevention strategy similarly recognises that people with long-term health conditions require targeted mental health support. Yet these policy frameworks appear to have made minimal impact on how cardiology services actually operate.

The 2025 consensus statements from major cardiology organisations reveal the scale of the oversight. The European Society of Cardiology endorses only routine screening for mental wellbeing, whilst the American Heart Association suggests symptom-prompted screening when patients present with obvious psychological distress. Neither approach represents systematic suicide prevention—the kind of comprehensive, proactive screening that cardiologists already provide for physical risk factors.

The Patient Health Questionnaire-9 (PHQ-9)—a validated tool for assessing depression severity and suicide risk—is mentioned in both guidelines but appears to be treated as an optional addition rather than a core component of cardiac care pathways.

There is encouraging evidence that targeted psychological intervention can benefit cardiac patients. Research examining the outcomes of NHS psychological therapy services found that when patients with depression receiving treatment achieved reliable improvement, they experienced a 12 per cent reduction in cardiovascular disease risk over the following three years. For patients aged under 60, the risk reduction was even greater at 15 per cent. This suggests that mental health support is not merely a quality-of-life measure but can directly improve physical health outcomes.

Such findings underline the dual imperative: treating psychiatric conditions in cardiac patients is both a moral necessity and clinically justified by evidence of improved physical health outcomes.

The BMJ editorial highlights how two major international consensus statements in 2025 represented “missed opportunities to prioritise suicide prevention.” The question is not whether cardiologists should engage in suicide prevention—the evidence demands it—but how NHS cardiac services, hospital trusts, and individual cardiologists can systematically integrate mental health screening and prevention into their standard practice.

Barriers likely include time constraints within already-pressured NHS services, lack of training in mental health assessment, uncertainty about how to respond when risk is identified, and the professional culture of cardiology, which has historically focused on physiological biomarkers rather than psychological wellbeing. Yet these barriers are not insurmountable. Other medical specialties have successfully embedded mental health screening into routine care.

The editorial calls for cardiology to move beyond tokenistic mental health acknowledgement to genuine, systematic suicide prevention. This would require:

• Routine use of validated suicide risk screening tools at key points in cardiac care pathways
• Training for cardiologists and cardiac nurses in mental health assessment and crisis response
• Clear pathways for referring patients to mental health services, including NHS talking therapies (IAPT services) and specialist cardiac psychology support where available
• Integration of mental health outcomes into cardiac service quality metrics

For patient safety and improved outcomes, the time for cardiology to take up this responsibility is now.

Key Takeaways

• People with serious heart conditions are 2–4 times more likely to die by suicide than the general population
• Patients hospitalised with cardiovascular disease face a particularly acute mental health crisis within the first year following their diagnosis
• Major international cardiology guidelines published in 2025 fail to prioritise suicide prevention adequately
• Evidence shows that successful treatment of depression in cardiac patients is associated with reduced cardiovascular risk, demonstrating the physical health benefits of mental health support

What This Means for Kent Residents

For Kent residents with heart conditions under the care of NHS Kent and Medway ICB and local hospital trusts, this research highlights the importance of proactively discussing mental health with your cardiologist or cardiac nurse. If you have experienced a cardiovascular event and are struggling emotionally, do not wait for services to ask—raise your concerns directly. You can access NHS talking therapies through your GP or contact IAPT services directly in Kent and Medway. The Kent and Medway Mental Health NHS Trust also provides specialist mental health support. Suicide prevention starts with conversation. If you or someone you know is in crisis, contact Samaritans on 116 123 (available 24 hours) or your local GP and A&E services.